Miraca Life Sciences Inc. waived its chance to argue that a False Claims Act whistleblower’s retaliation claim should be resolved in arbitration, the U.S. Court of Appeals for the Sixth Circuit said.
Paul Dorsa filed an FCA suit accusing Miraca, a laboratory company which is now Inform Diagnostics Inc., of filing Medicare claims that were tainted by kickbacks in 2013. His suit led to a $63.5 million settlement in 2019 that didn’t cover his retaliation claim, the court said.
Miraca asserted that Dorsa’s employment agreement with the company required the retaliation claim to be resolved by an arbitrator, not a ...
Learn more about a Bloomberg Law subscription.
Quince is looking to sidestep a proposed class action lawsuit accusing it of “defraud[ing] customers as to the value of thousands of … products sold on its website.” In a newly filed motion to dis...